Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Mouth Neoplasms 4 Breast Neoplasms 4 Squamous Cell Carcinoma of Head and Neck 3 Uterine Cervical Neoplasms 2 Triple Negative Breast Neoplasms 1 Sentinel Lymph Node Biopsy (SLNB) 1 Recurrence 1 Penile Neoplasms 1 Pancreatic Neoplasms 1 Ovarian Neoplasms 1 Melanoma 1 Lymphatic Metastasis 1 Endometrial Neoplasms 1 Eccrine Porocarcinoma 1 Carcinoma, Squamous Cell 1 Carcinoma, Merkel Cell 1 Carcinoma, Intraductal, Noninfiltrating 1 Breast Carcinoma In Situ 1

Interventions

Cyclophosphamide 23 venetoclax 17 Dexamethasone 16 pembrolizumab 15 fludarabine 15 Cytarabine 13 pomalidomide 8 Rituximab 8 Gemcitabine 8 Carboplatin 8 Azacitidine 8 glofitamab 7 fludarabine phosphate 7 Lenalidomide 7 selinexor 6 Paclitaxel 6 Injections 6 Immunotherapy, Adoptive 6 Granulocyte Colony-Stimulating Factor 6 Cisplatin 6 daratumumab 5 Temozolomide 5 Bevacizumab 5 zanubrutinib 4 ruxolitinib 4 Surgical Procedures, Operative 4 Oxaliplatin 4 Nivolumab 4 Drug Therapy 4 Decitabine 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × Recurrence × Sentinel Lymph Node Biopsy × Clear all

NCT03719547 2025-07-01

RACC

Karolinska Institutet

Phase NA Recruiting

Uterine Cervical Neoplasms, Recurrence

Data powered by HemOnc (CC BY 4.0) Colophon ⚡